{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:03:48Z","timestamp":1790388228912,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30973189"],"award-info":[{"award-number":["30973189"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Liao Ning Province","award":["2013021040"],"award-info":[{"award-number":["2013021040"]}]},{"name":"Doctoral Program of Higher Education (Specialized Research Fund) of China","award":["20132104110014"],"award-info":[{"award-number":["20132104110014"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.yexmp.2015.11.030","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T18:49:25Z","timestamp":1450118965000},"page":"139-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Over-expression of nuclear NF-\u03baB1 and c-Rel correlates with chemoresistance and prognosis of serous epithelial ovarian cancer"],"prefix":"10.1016","volume":"100","author":[{"given":"Ting","family":"Shuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2015.11.030_bb0005","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0025-6196(11)61196-8","article-title":"Current management strategies for ovarian cancer","volume":"82","author":"Aletti","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.yexmp.2015.11.030_bb0010","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1002\/cncr.25190","article-title":"Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer","volume":"116","author":"Annunziata","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.yexmp.2015.11.030_bb0015","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1182\/blood-2007-10-120832","article-title":"NF-kappaB1 and c-Rel cooperate to promote the survival of TLR4-activated B cells by neutralizing Bim via distinct mechanisms","volume":"112","author":"Banerjee","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2015.11.030_bb0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.yexmp.2015.11.030_bb0025","first-page":"1367","article-title":"Rel\/NF-kappaB\/IkappaB proteins and cancer","volume":"13","author":"Gilmore","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.yexmp.2015.11.030_bb0030","doi-asserted-by":"crossref","first-page":"178410","DOI":"10.1155\/2014\/178410","article-title":"Metadherin, p50, and p65 expression in epithelial ovarian neoplasms: an immunohistochemical study","volume":"2014","author":"Giopanou","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.yexmp.2015.11.030_bb0035","first-page":"1321","article-title":"The subunit composition of NF-kappa B complexes changes during B-cell development","volume":"5","author":"Grumont","year":"1994","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.yexmp.2015.11.030_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1757-2215-3-8","article-title":"The detection, treatment, and biology of epithelial ovarian cancer","volume":"3","author":"Gubbels","year":"2010","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.yexmp.2015.11.030_bb0045","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1111\/j.1742-4658.2009.07237.x","article-title":"MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1","volume":"276","author":"Guo","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.yexmp.2015.11.030_bb0050","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1440-1827.2008.02306.x","article-title":"Increased staining for phosphorylated AKT and nuclear factor-kappaB p65 and their relationship with prognosis in epithelial ovarian cancer","volume":"58","author":"Guo","year":"2008","journal-title":"Pathol. Int."},{"key":"10.1016\/j.yexmp.2015.11.030_bb0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1359-6101(00)00018-6","article-title":"NF-kappaB and cell-cycle regulation: the cyclin connection","volume":"12","author":"Joyce","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.yexmp.2015.11.030_bb0060","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1038\/sj.onc.1203219","article-title":"How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex","volume":"18","author":"Karin","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.yexmp.2015.11.030_bb0065","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2015.11.030_bb0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni0302-221","article-title":"NF-kappaB at the crossroads of life and death","volume":"3","author":"Karin","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yexmp.2015.11.030_bb0075","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1101\/gad.9.16.1965","article-title":"Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression","volume":"9","author":"Kontgen","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexmp.2015.11.030_bb0080","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1158\/1078-0432.CCR-06-3072","article-title":"Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway","volume":"13","author":"Lin","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"Suppl. 3","key":"10.1016\/j.yexmp.2015.11.030_bb0085","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.bjc.6601494","article-title":"Primary ovarian cancer chemotherapy: current standards of care","volume":"89","author":"McGuire","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexmp.2015.11.030_bb0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0092-8674(95)90415-8","article-title":"Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses","volume":"80","author":"Sha","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.yexmp.2015.11.030_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480015002543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480015002543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T02:21:12Z","timestamp":1537150872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480015002543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0014480015002543"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2015.11.030","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Over-expression of nuclear NF-\u03baB1 and c-Rel correlates with chemoresistance and prognosis of serous epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2015.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}